MC: Pulmonary Hypertension - Expert Didactics and Discussion
Image For Activity Cover
2 Courses
Expires on Oct 04, 2024
Credit Offered
4.25 CME / CE Credits
4.25 MOC Points
4.25 RN Credits
4.25 PA Credits
4.25 AANPCB Credits
There have been rapid recent advances in the field of pulmonary hypertension, including exciting new drug targets in clinical trials. Despite these advances, diagnosis and appropriate treatment selection remain a challenge. This course will provide an in-depth exploration of pulmonary hypertension pathophysiology, diagnostic strategies, and therapies, both current and future, as expert faculty discuss updated guidelines, complex cases, and unique clinical scenarios.
This activity is supported by an educational grant from Actelion Pharmceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson
  1. Understand the pathophysiology of PAH and the treatment algorithms.
  2. Interpret the hemodynamics—distinguish the precapillary and postcapillary PH.
  3. How to diagnose and treat PH when it complicates lung disease.
  4. Discuss and learn to manage unique and complex clinical scenarios.

© 2024 | American College of Chest Physicians®

Android App Download IOS App Download Powered By